All In Biotech

Drug Trial Radar · NCT06613763

A Study of RAY1225 in Participants With Impaired Kidney Function

Pharmacokinetics of RAY1225 Following Administration to Subjects With Impaired Renal Function

Last checked: Nov 19, 2026Latest source record: Mar 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

32

Actual

Start

Sep 11, 2024

Primary completion

Jan 10, 2025

Study completion Jan 20, 2025

Sponsor

Sponsor type
Industry
First posted
Sep 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess how fast RAY1225 gets into the blood stream and how long it takes the body to remove it in participants with impaired kidney function compared to healthy participants.

Conditions

  • Kidney Impairment

Interventions

  • RAY1225Drug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of RAY1225 From Time Zero to T (AUC[0-t])Time frame: Baseline through Day 43
  2. PK: Maximum Concentration of RAY1225Time frame: Baseline through Day 43

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.